Loading stock data…
$3.32+0.42 (+14.48%)
Cryo-Cell International, Inc.
Cryo-Cell International, Inc. in the Healthcare sector is trading at $3.32 with a market capitalization of $29M. The stock is currently 39% below its 52-week high of $5.43, remaining 11.7% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Total Revenue | $7.68M↓ | $7.84M↓ | $7.93M↓ | $7.97M↓ | $8.02M |
| Gross Profit | $6.03M↓ | $6.11M↑ | $6.07M↑ | $5.98M↓ | $6.39M |
| Operating Income | $765,134↑ | $392,047↓ | $1.49M↑ | $1.06M↑ | -$123,382 |
| Net Income | $47,108↑ | -$3.82M↓ | $355,785↑ | $282,855↑ | -$1.86M |
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical co...